Safety and efficacy of NEPA, an oral fixed combination of netupitant and palonosetron, in older patients-Reference-Cited by-同舟云学术

Safety and efficacy of NEPA, an oral fixed combination of netupitant and palonosetron, in older patients

Published:2017-01 Issue:1 Volume:8 Page:56-63
ISSN:1879-4068
Container-title:Journal of Geriatric Oncology
language:en
Short-container-title:Journal of Geriatric Oncology

Author:

Aapro Matti,Jordan Karin,Gralla Richard J.,Rizzi Giada,Rossi Giorgia,Palmas Marco,Alyasova Anna V.,Lisyanskaya Alla S.,Bošnjak Snežana M.,Hesketh Paul J.

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Oncology

Reference47 articles.

1. World Cancer Report 2014;International Agency for Research on Cancer,2014

2. European cancer mortality predictions for the year 2014;Malvezzi;Ann Oncol,2014

3. Cancer in older patients: an analysis of elderly oncology;Swaminathan;Ecancermedicalscience,2012

4. Cancer treatment in the elderly: the need for a better organization;Monfardini;Ann Oncol,2007

5. Cancer and comorbidity: redefining chronic diseases;Ogle;Cancer,2000

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dexamethasone-sparing regimens with NEPA (netupitant/palonosetron) for the prevention of chemotherapy-induced nausea and vomiting in older patients (>65 years) fit for cisplatin: A sub-analysis from a phase 3 study;Journal of Geriatric Oncology;2023-07

2. Prevention of Chemotherapy-Induced Nausea and Vomiting in the Older Patient: Optimizing Outcomes;Drugs & Aging;2021-12-09

3. MASCC antiemetics in advanced cancer updated guideline;Supportive Care in Cancer;2021-08-16

4. Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting;Drugs;2021-07

5. Improving Nausea and Vomiting Post-Elipse Balloon: a Novel Single-Dose Regimen of 300 mg Netupitant/0.5 mg Palonosetron Hydrochloride;Obesity Surgery;2019-05-18